Aug 31 (Reuters) - Creso Pharma Ltd (CPH) :
- HY REVENUE FROM ORDINARY ACTIVITIES A$4.3 MILLION VERSUS A$3 MILLION
- HY NET LOSS ATTRIBUTABLE A$7.1 MILLION VERSUS LOSS OF A$19.0 MILLION
News: CPH Creso Pharma Posts HY Revenue From Ordinary Activities A$4.3 Million
Add to My Watchlist
What is My Watchlist?